ALZHEIMER'S DISEASES INSIGHTS: FROM MECHANISM TO TREATMENT

Alzheimer’s disease is the progressive neurodegenerative disease leading cause of dementia, slowly destroying memory, thinking, and independence until daily basic life becomes impossible. WHO stated Alzheimer’s been the most fatal disease and occurring older adults. The Alzheimer’s disease follows the hypothesis which are amyloid hypothesis and Tau hypothesis. Fragment of a protein called amyloid accumulates outside neurons, forming sticky plaque. These plaques disturb communication between cells, trigger inflammation, and set off toxic chemical reaction that damage brain tissue. Hand in hand amyloid comes in tau pathway, tau is a protein that normally stabilize the cell internal transport system. In Alzheimer’s tau becomes abnormally modified, clumping together into twisted tangles inside neurons. These tangles block the transport of nutrients and signals, causing the affected cells to weaken and die. Treating Alzheimer’s has always been difficult because the disease involves many damaging processes at once. The first treatment focus on symptom relief drugs like-donepezil, rivastigmine, and galantamine boost acetylcholine to support memory, while memantine helps protect neurons grom glutamate overload. These provide temporary benefits but do not stop progression. More recently, therapies have turned to the roots of the disease. Antibody drugs such as Aducanumab and donanemab target and clear amyloid plaques, showing some ability to slow decline, though side effects remain a concern. Hence current treatments only aim to slow decline, not to regenerate or repair damaged neurons. This review is covered based on the information subject to various source for scientific, technical, and medical research like science direct, Scopus, Web of science, PubMed etc.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-11
DOI
https://doi.org/10.5281/zenodo.17580368
Primary Topic
Pharmacology and Nanomedicine Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALZHEIMER'S DISEASES INSIGHTS: FROM MECHANISM TO TREATMENT

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Nanomedicine Research
article

ALZHEIMER'S DISEASES INSIGHTS: FROM MECHANISM TO TREATMENT

article en

Abstract

Alzheimer’s disease is the progressive neurodegenerative disease leading cause of dementia, slowly destroying memory, thinking, and independence until daily basic life becomes impossible. WHO stated Alzheimer’s been the most fatal disease and occurring older adults. The Alzheimer’s disease follows the hypothesis which are amyloid hypothesis and Tau hypothesis. Fragment of a protein called amyloid accumulates outside neurons, forming sticky plaque. These plaques disturb communication between cells, trigger inflammation, and set off toxic chemical reaction that damage brain tissue. Hand in hand amyloid comes in tau pathway, tau is a protein that normally stabilize the cell internal transport system. In Alzheimer’s tau becomes abnormally modified, clumping together into twisted tangles inside neurons. These tangles block the transport of nutrients and signals, causing the affected cells to weaken and die. Treating Alzheimer’s has always been difficult because the disease involves many damaging processes at once. The first treatment focus on symptom relief drugs like-donepezil, rivastigmine, and galantamine boost acetylcholine to support memory, while memantine helps protect neurons grom glutamate overload. These provide temporary benefits but do not stop progression. More recently, therapies have turned to the roots of the disease. Antibody drugs such as Aducanumab and donanemab target and clear amyloid plaques, showing some ability to slow decline, though side effects remain a concern. Hence current treatments only aim to slow decline, not to regenerate or repair damaged neurons. This review is covered based on the information subject to various source for scientific, technical, and medical research like science direct, Scopus, Web of science, PubMed etc.

Zenodo (CERN European Organization for Nuclear Research)
Dr. A.P.J. Abdul Kalam Technical University (IN)
Good health and well-being
Openalex Percentile: Top 29%
Pharmacology and Nanomedicine Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.